”What results were found from your investigation?
It did mimic the effects that we see in the clinical scenario. It has been exciting. The other nice thing about this model is it doesn't have to only be utilized for bone sarcomas and creates the microenvironment from which a bone sarcoma might arise. However, we can also use it for secondary carcinomas that migrate to or metastasize to the bone marrow; metastatic bone disease in other words, where breast, prostate, lung, thyroid, and renal cell cancers all have a predilection for metastasizing to the bone marrow or in the bone.”